Posted by Michael Wonder on 22 Aug 2022
EMA’s Emergency Task Force advises on intradermal use of Imvanex/Jynneos against monkeypox
19 August 2022 - EMA’s Emergency Task Force (ETF) has reviewed data on the monkeypox vaccine Imvanex used as an intradermal injection.
The vaccine is only authorised for subcutaneous injection (injection under the skin). However, when given intradermally, a smaller dose of the vaccine can be used. Given the currently limited supply of the vaccine, this means that more people can be vaccinated.
